semaglutide in chronic kidney disease Long-term outcomes of obesity and cardiovascular in the SELECT trial FLOWing with the SemagluTIDE —

Rotate injection sites (alternating deltoids, vastus lateralis, or ventrogluteal areas) and ensure you're injecting intramuscularly, not subcutaneously

Cycle driver: GHK-Cu copper cycling (typically 30-60 days on, equal time off) usually governs the entire GLOW cycle

This recall affected 751 vials of the medication and expires on September 24, 2024

I hope the cops investigate this case!! We cant disagree that a child injecting themselves intentionally doesnt seem likely, but thats not to say it didnt happen

Unsupervised medication use carries real risks Getting GLP-1 medications from a telehealth mill without proper labs or monitoring can lead to side effects and poor outcomes